<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00399919</url>
  </required_header>
  <id_info>
    <org_study_id>ST 04-302</org_study_id>
    <nct_id>NCT00399919</nct_id>
  </id_info>
  <brief_title>Safety and Efficacy of Propionyl-L-Carnitine in the Treatment of Peripheral Arterial Disease (Intermittent Claudication)</brief_title>
  <official_title>Safety and Efficacy pf Propionyl-L-Carnitine in Combination With Monitored Exercise Training in Peripheral Arterial Disease (Intermittent Claudication).</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sigma-Tau Research, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Colorado Prevention Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Sigma-Tau Research, Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients with peripheral artery disease have decreased blood flow to exercising muscle
      causing pain. This decreased blood flow to the muscle affects the level of acylcarnitines
      which in turn decreases the level of carnitine. Carnitine allows muscles to function
      properly. This study will test the safety and efficacy of Propionyl-L-Carnitine taken in
      combination with a monitored exercise training program.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To test the hypothesis that Propionyl-L-Carnitine taken in combination with monitored
      exercise training may improve exercise performance the study will randomize male or female
      adults with peripheral artery disease and claudication to receive either
      Proprionyl-L-Carnitine or Placebo.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2006</start_date>
  <completion_date type="Actual">March 2008</completion_date>
  <primary_completion_date type="Actual">March 2008</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Peak walking time</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Claudication onset time, activity level and quality of life</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">69</enrollment>
  <condition>Peripheral Vascular Diseases</condition>
  <condition>Intermittent Claudication</condition>
  <arm_group>
    <arm_group_label>PLC</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Investigational drug</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propionyl-L-Carnitine</intervention_name>
    <description>2 grams per day for six months</description>
    <arm_group_label>PLC</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>PLC</intervention_name>
    <description>2 grams/day for six months</description>
    <arm_group_label>PLC</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Ambulatory outpatient who are able to exercise

          -  Intermittent claudication due to peripheral artery disease

          -  Willingness to participate in a monitored exercise training program

        Exclusion Criteria:

          -  Pain at rest, ischemic ulcerations, gangrene of the lower extremity

          -  Peripheral Artery Disease of a non-atherosclerotic nature

          -  Any disease process other than PAD, that may interfere with performance during the
             treadmill test or prevent the subject from reaching their claudication-limited PWT

          -  Current participation in an exercise training program or previous participtation in a
             monitored exercise training program within 6 months of the screening visit.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Edgar Carell</last_name>
    <role>Principal Investigator</role>
    <affiliation>Western Suburban Cardiologists, Ltd.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kenneth Morris</last_name>
    <role>Principal Investigator</role>
    <affiliation>Durham VA Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Bruce Cutler</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Massachusetts, Worcester</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Robert McLafferty</last_name>
    <role>Principal Investigator</role>
    <affiliation>SIU School of Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Richard Powell</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dartmouth-Hitchcock Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Layne Yonehiro</last_name>
    <role>Principal Investigator</role>
    <affiliation>Baptist Clinical Research</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Karl Illig</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Rochester</affiliation>
  </overall_official>
  <overall_official>
    <last_name>William Abernethy</last_name>
    <role>Principal Investigator</role>
    <affiliation>Asheville Cardiology Associates</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Michael Koren</last_name>
    <role>Principal Investigator</role>
    <affiliation>Jacksonville Clinical Research Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Jacksonville Center for Clinical Research</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32216</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Baptist Clinical Research</name>
      <address>
        <city>Pensacola</city>
        <state>Florida</state>
        <zip>32501</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Western Suburban Cardiologists, Ltd.</name>
      <address>
        <city>LaGrange</city>
        <state>Illinois</state>
        <zip>60525</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>SIU School of Medicine</name>
      <address>
        <city>Springfield</city>
        <state>Illinois</state>
        <zip>62702</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Massachusetts Medical Center</name>
      <address>
        <city>Worchester</city>
        <state>Massachusetts</state>
        <zip>01655</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dartmouth-Hitchcock Medical Center</name>
      <address>
        <city>Lebanon</city>
        <state>New Hampshire</state>
        <zip>03756</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Rochester Medical Center</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14618</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Asheville Cardiology Associates</name>
      <address>
        <city>Asheville</city>
        <state>North Carolina</state>
        <zip>28803</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Durham VA Medical Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27705</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 14, 2006</study_first_submitted>
  <study_first_submitted_qc>November 14, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 15, 2006</study_first_posted>
  <last_update_submitted>August 23, 2011</last_update_submitted>
  <last_update_submitted_qc>August 23, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 25, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Perhipheral Artery Disease</keyword>
  <keyword>Claudication</keyword>
  <keyword>Exercise</keyword>
  <keyword>Intermittent Claudication due to Peripheral Artery Disease</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vascular Diseases</mesh_term>
    <mesh_term>Peripheral Arterial Disease</mesh_term>
    <mesh_term>Peripheral Vascular Diseases</mesh_term>
    <mesh_term>Intermittent Claudication</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

